Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells

BACKGROUND: EPH (erythropoietin-producing hepatocellular) receptors are clinically relevant targets in several malignancies. This report describes the effects of GLPG1790, a new potent pan-EPH inhibitor, in human embryonal rhabdomyosarcoma (ERMS) cell lines. METHODS: EPH-A2 and Ephrin-A1 mRNA expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Megiorni, Francesca, Gravina, Giovanni Luca, Camero, Simona, Ceccarelli, Simona, Del Fattore, Andrea, Desiderio, Vincenzo, Papaccio, Federica, McDowell, Heather P., Shukla, Rajeev, Pizzuti, Antonio, Beirinckx, Filip, Pujuguet, Philippe, Saniere, Laurent, der Aar, Ellen Van, Maggio, Roberto, De Felice, Francesca, Marchese, Cinzia, Dominici, Carlo, Tombolini, Vincenzo, Festuccia, Claudio, Marampon, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389084/
https://www.ncbi.nlm.nih.gov/pubmed/28985758
http://dx.doi.org/10.1186/s13045-017-0530-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389084/
https://www.ncbi.nlm.nih.gov/pubmed/28985758
http://dx.doi.org/10.1186/s13045-017-0530-z

Ejemplares similares